2025
The implementation of artificial intelligence in serial monitoring of post gamma knife vestibular schwannomas: A pilot study
Singh M, Jester N, Lorr S, Briano A, Schwartz N, Mahajan A, Chiang V, Tommasini S, Wiznia D, Buono F. The implementation of artificial intelligence in serial monitoring of post gamma knife vestibular schwannomas: A pilot study. Clinical Imaging 2025, 123: 110495. PMID: 40388858, DOI: 10.1016/j.clinimag.2025.110495.Peer-Reviewed Original ResearchConceptsGamma knife radiosurgeryVestibular schwannomaPost-GKSTumor growthVS volumeHalting tumor growthRetrospective cohort studyAssess treatment efficacyManual segmentationHearing lossBenign tumorsPaired t-testT1-weighted MRI scansAssess statistical significanceCohort studyDice similarity coefficientNeurological functionTreatment efficacyClinical monitoringMRI scansStatistical significancePercentage changeSchwannomaSpatial overlapTumorPrevalence and risk factors for underlying vestibular weakness in cochlear implant candidates
Reeder A, Shah R, Canner J, Schneider E, Vining E, Kveton J, Schwartz N. Prevalence and risk factors for underlying vestibular weakness in cochlear implant candidates. European Archives Of Oto-Rhino-Laryngology 2025, 1-8. PMID: 40195189, DOI: 10.1007/s00405-025-09361-5.Peer-Reviewed Original ResearchCochlear implant candidatesVestibular weaknessImplant candidatesSeverity of hearing lossAudiological risk factorsRisk factorsDesignRetrospective cohort studyHigh riskCI candidatesHearing earIndicator of high riskAudiological dataHearing lossVestibular evaluationVNG testCaloric testUnilateral weaknessVestibular functionVestibular dysfunctionStudy designRetrospective cohort studyBilateral weaknessCohort studyAcademic hospitalDemographic variablesMedical comorbiditiesRisk factors for underlying bilateral vestibular weakness in cochlear implant candidates
Reeder A, Canner J, Schwartz N. Risk factors for underlying bilateral vestibular weakness in cochlear implant candidates. Otology & Neurotology Open 2025, 5: e066-e066. PMID: 40161476, PMCID: PMC11949288, DOI: 10.1097/ono.0000000000000066.Peer-Reviewed Original ResearchBilateral vestibular weaknessVestibular weaknessBilateral weaknessQuality of lifeCochlear implantationAudiological dataVestibular dysfunctionWorse-hearing earCochlear implant candidatesHigher body mass indexBody mass indexCI candidatesImplanted earHearing thresholdsImplant candidatesPrognostic indicatorVestibular evaluationRetrospective cohort studyVestibular testsCaloric testUnilateral weaknessVestibular functionCohort studyMass indexRisk factors
2023
Hydroxyapatite Use in Repair of Lateral Skull Base CSF Leaks Via Transmastoid Approach: When Does It Work?
Shah R, Kveton J, Schwartz N. Hydroxyapatite Use in Repair of Lateral Skull Base CSF Leaks Via Transmastoid Approach: When Does It Work? Otology & Neurotology 2023, 44: 804-808. PMID: 37550871, DOI: 10.1097/mao.0000000000003973.Peer-Reviewed Original ResearchConceptsCSF leak repairTransmastoid approachTertiary level care hospitalSkull Base Cerebrospinal Fluid LeaksLeak repairHydroxyapatite cementPrior smoking historyTrans-mastoid approachPatients 18 yearsRetrospective cohort studyRecurrence of symptomsVP shunt placementPatient demographic factorsBenign intracranial hypertensionSpontaneous CSF leaksCerebrospinal fluid leakFailure rateSkull base repairAverage defect sizeRepair cohortRecurrent symptomsAdjuvant treatmentFormer smokersSmoking historyCohort study
2013
Thyroid Surgery in the Elderly
Schwartz N, Shpitzer T, Feinmesser R, Robenshtok E, Bachar G. Thyroid Surgery in the Elderly. Gerontology 2013, 59: 401-407. PMID: 23988591, DOI: 10.1159/000351197.Peer-Reviewed Original ResearchConceptsOlder patientsThyroid diseaseIndividual risk-benefit analysisOlder groupPrevalence of comorbiditiesRetrospective cohort studyExtent of surgeryTertiary medical centerAdvanced disease stageBetween-group differencesRisk-benefit analysisBasis of ageMore comorbiditiesAdvanced diseasePostoperative complicationsTotal thyroidectomyCohort studyElderly patientsYounger patientsMedical chartsDistant metastasisHistologic subtypeSurgical managementOperative managementRecurrence rate
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply